3:12 AM MYT WASHINGTON, Dec. 28 (Xinhua) The Phase 3 trial of another investigational COVID-19 vaccine has begun enrolling adult volunteers, the U.S. National Institutes of Health (NIH) announced on Monday. The randomized, placebo-controlled trial will enroll approximately 30,000 people at approximately 115 sites in the United States and Mexico. It will evaluate the safety and efficacy of NVX-CoV2373, a vaccine candidate developed by biotechnology company Novavax, Inc. Volunteers will be asked to give informed consent prior to their participation in the trial. They will be grouped into two cohorts: individuals 18 through 64 years old and those aged 65 and older, with a goal of enrolling at least 25 percent of all volunteers who are 65 years old or older.
Statewide coronavirus update: Indiana reports 2,494 cases, 43 deaths IndyStar, Indianapolis Star
Replay Video UP NEXT
The Indiana State Department of Health on Monday reported 2,494 additional COVID-19 cases and 43 more deaths.
These additions bring the state to more than 496,000 cases and 7,539 confirmed COVID-19 deaths.
Here are some other statistics of note:
The number of people in Indiana hospitals with COVID-19: 2,866.
Intensive care unit-bed availability: 25.9% of 2,136 beds available. 29.6% of the total beds are occupied by COVID-19 patients.
Ventilator availability: 69.5% available. 13% of total ventilators are in use by COVID-19 patients.
Counties with 100 or more newly reported cases: Marion (307), Hamilton (172), Lake (170), Vanderburgh (161), Allen (128).
Other counties with 50 or more newly reported cases: Porter (93), Elkhart (87), Saint Joseph (77), Johnson (73), Madison (66), LaPorte (63), Hancock (54), Hendricks (51).
Wisconsin reports 2,287 new virus cases, 9 new deaths Photo: NIAID-RML via AP. FILE - This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. On Tuesday, April 21, 2020, U.S. health regulators OK d the first coronavirus test that allows people to collect their own sample at home, a new approach that could help expand testing options in most states. The sample will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.
Roundup: Phase 3 trial of Novavax investigational COVID-19 vaccine starts china.org.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from china.org.cn Daily Mail and Mail on Sunday newspapers.
Please share this article - Go to very top of page, right hand side, for social media buttons.
As a physician scientist, I study how the virus has evolved over the pandemic, since any changes in the virus could also change the effectiveness of current treatments. On Nov. 9, Pfizer announced preliminary trial results showing that a vaccine it developed with BioNTech was about 90 per cent effective. That was followed up nine days later with final trial results and two months of safety data, indicating a 95 per cent effectiveness rate.
Pfizer announced on Nov. 18 that it intends to file for emergency authorization with the U.S. Food and Drug Administration.